Abstract:Matrix metalloproteinases are involved in a complex multifactorial process of atherosclerotic plaque formation and play a leading role in the degradation of the extracellular matrix components and increase the migratory activity of cellular elements of the vascular wall. Despite a number of scientific studies, it is necessary to identify clear biochemical markers for the development of atherosclerotic lesions. The purpose of the study was to investigate the relationship between the activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in myocardial homogenate with changes of the cells composition in the coronary arteries wall in experimental atherosclerosis. Materials and methods. The studies were performed on 76 nonlinear rats, which were divided into 3 groups: group Ia was the control (n=20) – animals, injected intracutaneously with 0.1 ml of 0.9 % sodium chloride solution; Ib – comparison group (n=20) – animals injected with incomplete Freund’s adjuvant at the dose of 0.1 ml intracutaneously and II – experimental group (n=36), which were immunized with native human low-density lipoprotein at a single dose of 200 μg, diluted in 0.1 ml of incomplete Freund’s adjuvant, regardless of the weight. The experiment lasted for 20 weeks. Material sampling was performed, starting from the 4th week after the drug administration. From the coronary arteries and the adjacent myocardium, microslides were made according to the generally accepted technique, which were stained with hematoxylin and eosin, according to the methods of Van Gizon, Mallory and Sudan III. The activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 was determined by enzyme-zimografic method. Results and discussion. The growth of matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in atherosclerotic lesions showed stages of degradation of extracellular matrix components: the dynamics of matrix metalloproteinase-2 activity during the experiment increased from 109.1±1.23 % at the 12th week to 127.32±0.99 % at the 20th week. The increased activity of matrix metalloproteinase-2 was associated with an increase in the number of leukocytes and macrophages, including foam cells. The activity of matrix metalloproteinase-9 reached the highest values of 98.24±0.82% at the 8th period from the onset of changes to the final level of 86.26±0.54% at the maximum terms of the experiment. Conclusion. The growing activity of matrix metalloproteinase-9 indicated the development of early atherosclerotic lesions, while the high level of activity of matrix metalloproteinase-2 indicated significant structural changes in the wall of the coronary arteries

Relation of Metalloproteinase 9 and Its Inhibitor with Carotid Artery Atherosclerosis in Aged Patients with Hypertension

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

The Marker of Unstable Carotid Atheromatous Plaque in Cerebral Infarction Patients

The Changes of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in Essential Hypertension

Relations of serum MMP-1 and MMP-9 levels with left ventricular hypertrophy in the elderly with hypertension

Value of Matrix Metalloproteinase - 9 and Ischemia - Modified Albumin for Diagnosis of Coronary Heart Disease

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

The Study of Relationship Between Leukotriene B4(LT-B4) ,matrix Metallopeptidase 9 (MMP-9) and Stability of Carotid Plaques

Study of Androgen and Atherosclerosis in Old-Age Male

Correlations among the serum levels of matrix metalloproteinase-9 and its gene C1562T polymorphism and the stability of carotid arteriosclerotic plaque in Uygur patients with cerebral infarction

Relationship Between the Prothrombotic State and Leukoaraiosis in Elderly Patients with Metabolic Syndrome

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

Study on Atherosclerotic Plaque Composition in Patients with Intermediate Coronary Stenosis by Multidetector Computed Tomography Angiography,serum Matrix Metalloproteinase 9 and Soluble CD40 Ligand

CALCIUM ANTAGONIST COMBINED WITH STATIN THERAPY ON PLASMA INFLAMMATORY MEDIATORS IN PATIENTS WITH HYPERTENSION AND CAROTID ATHEROSCLEROSIS

Relationship Between Matrix Metalloproteinases-9 and Circadian Rhythm of Blood Pressure in Patients with Essential Hypertension

Relationship between the Activity of Matrix Metalloproteinase-2 and -9 in Myocardial Homogenate with Changes of the Cells Composition in the Coronary Arteries Wall in the Experiment

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

To Study on the Association Between the Carotid Intima-Media Thickness and Adult Obstructive Sleep Apnea Hypoventilation Syndrom

Effect of Carotid Atherosclerosis on Lacunar Infarction,Leukoencephalopathy and Cognition Disorders in Elderly Hy-pertension Patients

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels

Analysis of relationship between high- sensitivity C-reactive protein and carotid atherosclerosis in elderly hypertensive patients